Our Chief Operating Officer, Christopher Kennedy, recently presented at Pharma and Patient USA, a virtual event bringing together leaders in patient-centricity. Christopher shared our perspective on what it takes to deliver remarkable patient experiences to clinical trial participants.
In this in-depth guide, we look at all aspects of patient engagement across the entire clinical trial journey, and why it’s important in ensuring diversity amongst participants and looking after patients’ mental wellbeing.
There’s no doubt of the seismic impact COVID-19 has had on clinical trials. As a result of safety measures, the industry has had no choice but to start moving towards an approach which minimises or eliminates the need for travel and contact. As a result, more and more trials are being held virtually, and completely decentralised trials are increasingly more common.
Decentralisation of clinical trials has been a growing topic of discussion and development over the last few years, enabled further by the advancement of available technologies. Here, we explore what we mean when we talk about decentralised trials and discuss why the clinical research industry has been reluctant to pursue this route. We illuminate the […]
We explore how to look beyond the most common challenges faced by study organisers, and identify whether a clinical trial is an appropriate candidate for either a fully decentralised or hybrid model.
